Atlas Trials

Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 Parosmia

Clinical trial NCT05216614 · WITHDRAWN

Trial details

NCT number
NCT05216614
Sponsor
Washington University School of Medicine
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19Olfactory DisorderParosmia
Start date
2021-12-14
Primary completion
2022-02-22
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.